-transparent.png){kind=logo}
Fifteen patients with nonmetastatic gestational trophoblastic neoplasms were treated primarily with methotrexate and citrovorum factor. Complete and sustained remission was achieved in 14 of the 15 patients. Response to treatment was determined solely on the basis of serial serum human chorionic gonadotropin levels as measured by the beta subunit radioimmunoassay. All patients developed nonmetastatic gestational trophoblastic neoplasms following evacuation of a molar pregnancy. The known histologic diagnosis in all cases was hydatidiform mole. No significant toxicity was encountered despite careful monitoring of marrow, hepatic, renal, neurologic, and mucocutaneous parameters. Up to January 31, 1976, duration of remission ranged from 2 to 14 months.
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
May 1985,
American journal of obstetrics and gynecology,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
November 1989,
Zhonghua fu chan ke za zhi,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
June 1990,
Gynecologic oncology,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
February 1993,
Gynecologic oncology,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
June 1987,
Tumori,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
May 1967,
American journal of obstetrics and gynecology,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
June 1975,
The New England journal of medicine,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
September 1988,
Obstetrics and gynecology,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
November 1987,
American journal of obstetrics and gynecology,
D P Goldstein, and
P R Goldstein, and
P Bottomley, and
R Osathanondh, and
A R Marean
August 2001,
Gynecologic oncology,
